Ecosystem
Beta Site
Search Results
85 items found for "Lauren M Clubb"
- The GPCR-Gαs-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure
Robert Saddawi-Konefka , Zhiyong Wang , Alexander T Wenzel , Miranda J Song , Meghana S Pagadala , Lauren M Clubb , Joshua Chiou , Sanju Sinha , Marin Matic , Francesco Raimondi , Thomas S Hoang , Rebecca Berdeaux
- Ep 82 with Dr. Lauren M. Slosky
Lauren M. Slosky About Dr. Lauren M. Slosky Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member of the Lauren M.
- Ep 09 with Lauren Celano
GPCR Podcast << Back to podcast list Lauren Celano About this episode In this special Dr. GPCR podcast episode, we sat down to chat with Lauren Celano to talk about career options for Ph.D.’s Lauren has a science background and is passionate about helping talented scientists find their dream Lauren Celano on the web LinkedIn Propel Careers Email: Lauren@propelcareers.com Dr.
- GPCR Retreat 2023 - Part I
Lauren Slosky About Irfan Dhanidina "My interest in oncology research led me to pursue a BSc in Biology Kathleen Caron " "Kathleen M. Caron, Ph.D. is the Frederik L. Lauren Slosky "Lauren Slosky is an Assistant Professor in the Department of Pharmacology and a member Lauren Slosky on the web University of Minnesota Department Page Twitter LinkedIn Google Scholar PubMed
- Ep 140 with Dr Alix A J Rouault
I spent time running for the chair of International Affairs for the U-M Postdoctoral Association (UMPDA Lauren Slosky and Dr. Joshua Gross were enthusiastic about the idea and jumped on board.
- Ep 102 with Dr Caron Tribute Part 3
Lauren Sloksy (2020) Dr. Josh C Snyder (2012) Dr.
- Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through machine learning
to cladribine, high-dose cytarabine, granulocyte colony-stimulating factor, and mitoxantrone (CLAG-M) Comparing outcomes using CLAG-M/sorafenib with those of a matched cohort of 76 patients treated with CLAG-M alone, multivariable-adjusted survival estimates were improved for 41 patients receiving CLAG-M These data suggest that CLAG-M/sorafenib is safe and improves OS and EFS relative to CLAG-M alone, with
- Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia
Chien, Timothy J Martins, Brenda Loera, Quy H Nguyen, Melanie L Oakes, Bahar Tercan, Boris Aguilar, Lauren
- Ep 103 with Dr Kathleen Caron
Kathleen Caron About Kathleen M. Caron Kathleen M. Caron, Ph.D. is the Frederik L. Kathleen M.
- Interaction with the cell adhesion molecule NEGR1 affects mGluR5 cell signalling
signalling Date & Time Friday, November 3rd / 1:30 PM Abstract Coming Soon About Fabiola Ribeiro "Fabiola M. GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec
- "Have a nice weekend, and I'll see you tomorrow!": RAMP-interacting GPCR Pathways
Time Thursday, November 2nd / 4:30 PM Keynote Talk Abstract Coming Soon About Kathleen Caron "Kathleen M. GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec
- Protease-Activated Receptor-1 IgG Autoantibodies in Patients with COVID-19
Anne-Christin Beatrice Wilde, Pegah Ramezani Rad, Wolfgang Poller, Erik Asmus, Szandor Simmons, Wolfgang M Kuebler, Martin Witzenrath, Lajos Markó, Kai Jakobs, Marianna Puccini, David M Leistner, Ursula Rauch-Kröhnert
- GPCR Retreat 2023 - Part II
Lauren Slosky, she is working to understand the mechanism by which a new class of biased allosteric modulators
- Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19
Authors Florian Tran , Danielle M M Harris , Alena Scharmacher , Hanna Graßhoff , Kristina Sterner ,
- Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
NGF , NMU , NP , Na(v) , Nasal polyps , Nerve growth factor , Neuromedin U , OSM , OSMRβ , Oncostatin M , Oncostatin-M specific receptor subunit beta , PAR2 , PC(20) , PN , Protease activated receptor 2 , potential , Transient receptor potential ankyrin 1 , Transient receptor potential cation channel subfamily M member 4 , Transient receptor potential cation channel subfamily M member 8 , Transient receptor potential
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
Authors Anna B Halpern , Eduardo Rodríguez-Arbolí , Megan Othus , Kelsey-Leigh A Garcia , Mary-Elizabeth M S Appelbaum , Janis L Abkowitz , Johnnie J Orozco , Siobán B Keel , Paul C Hendrie , Bart L Scott , M
- Delivery of US28 by incoming HCMV particles rapidly attenuates Akt activity to suppress HCMV lytic replication in monocytes
Authors Jamil Mahmud, Brittany W Geiler, Juthi Biswas, Michael J Miller, Julia E Myers, Stephen M Matthews , Amanda B Wass, Christine M O'Connor, Gary C Chan Source Contribute to the GPCR News Coming soon Become
- Removing the GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte browning, and protects against diet-induced obesity
Hamm, Ph.D. is the Aileen M. GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec
- Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis
The predictive ability of the model was evaluated by Kaplan-Meier (K-M) survival analysis. K-M analysis of the prognostic model showed that it could differentiate high- and low-risk patients,
- G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β1-adrenergic receptor, a membrane-associated guanylate kinase (MAGUK) scaffold protein, and protein kinase A anchoring protein (AKAP) 5 in MCF7 breast cancer cells
Authors Julia Tutzauer , D Stephen Serafin , Tobias Schmidt , Björn Olde , Kathleen M Caron , L M Fredrik
- Ep 75 with Vaithish Velazhahan
mechanisms of flavonoids in cancer using nuclear magnetic resonance spectroscopy (NMR) led to a Barry M.
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Platform for Comprehensive Profiling of adhesion GPCR Signaling and Pharmacology-Enabling Drug Discovery Laurent , Canada (2) Department of Pharmacology-Physiology, Université de Sherbrooke, Québec, Canada" About Laurent Sabbagh "Laurent holds a Ph.D. in immunology from McGill University. Laurent is currently leading DTNA discovery group working on GPCRs in immuno-oncology to discover new Laurent Sabbagh on the web Domain Therapeutics Characterizing hADGRE5/CD97 Activation and Signaling:
- Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5
Walser , Stavroula Louka , Ida Aaberg Lillethorup , Jon Våbenø , Katrine Qvortrup , Paul Proost , Mette M
- Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors
Authors Bongers B J , Gorostiola González M , Wang X , van Vlijmen HWT , Jespers W , Gutiérrez-de-Terán
- Leukotriene B4 receptor 2 governs macrophage migration during tissue inflammation
Authors Ebru Ermis , Titli Nargis , Kierstin Webster , Sarah A Tersey , Ryan M Anderson , Raghavendra
- Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells
The percentage of cells in the S-M phase was decreased in MCF-7 cells treated with KS-133.
- In Silico Design of Novel RGS2-Galpha-q Interaction Inhibitors with Anticancer Activity
Bair, Natalie Printy, So Hee Choi, Joshua Wilkinson, Joseph O'Brien, Brian Myers, David Roman, Tarek M
- Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion
Qiaoying Wang , Edward Philip Carter , Nicolas Jaime Roth , Jessica Gibson , Ariana Samadi , Hemant M
